-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q1 2022 to Q1 2023.
- LakeShore Biopharma Co., Ltd. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending March 31, 2023 was ¥5.78M, a 25% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (CNY)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)